Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
Akira Kitamura, GM, AI Drug Development Division of NEC Corporation [...]
Akira Kitamura, GM, AI Drug Development Division of NEC Corporation [...]
Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite [...]
By studying how various biomolecules interact with each other – [...]
Each partner company has opted in to share operational data [...]
The new agents are the AI Protocol Conversion agent and [...]
Agreements strengthen proprietary foundation, enhance partnering readiness, and support regulatory [...]
Through a unique combination of sample-locking architecture, passive media exchange, [...]
Massive Bio introduces TrialRelay, a physician-facing operating system designed to [...]
Combined AI and Experimental Validation Platform Enables End-to-End Protein Binder [...]
Expansion of iXCells’ iPSCore platform with integration of 3D human [...]